Navigation Links
Global Specialty Enzymes Industry
Date:3/16/2011

p>

Product Definitions And Scope Of Study 3

Specialty Medical Enzymes 4

Polymerases 4

Nucleases 4

Other Specialty Enzymes 4

Pharmaceuticals/Diagnostic 4

Research/Biotechnology 4

2. GLOBAL MARKET OVERVIEW 5

Current and Future Analysis 5

Recession Derails the Market Momentum 6

Competitive Scenario 6

Table 1: Leading Players in the Global Enzyme Market (2009):

Percentage Breakdown of Value Sales for Novozymes, Danisco,

Genzyme, Roche, Allergan, DSM and Others (includes

corresponding Graph/Chart) 6

3. ENZYMES - A REVIEW 7

Definition 7

Introduction 7

Advantages of Enzymes Compared to Chemical Catalysts 8

A Brief History 8

4. SPECIALTY ENZYMES: AN OVERVIEW 9

Analysis of Product Segments 9

Specialty Medical Enzymes 9

Polymerases 10

Nucleases 10

Other Specialty Enzymes 10

5. ANALYSIS OF THE END-USE MARKETS 11

Pharmaceuticals & Diagnostics 11

Research/Biotechnology 11

Other End Use Markets 11

6. TECHNOLOGY TRENDS 12

Protein Engineering Technology 12

Specialty Enzymes in Industrial Uses 12

Enzyme Technology in Pig Industry 13

7. PRODUCT INTRODUCTIONS/INNOVATIONS 14

Verenium Launches Xylathin 14

Novagen Introduces Novagen® KOD XtremeTM Hot Start DNA

Polymerase Kit 14

Verenium Launches New Veretase High-Performance Enzyme 14

8. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST -

A PERSPECTIVE BUILDER 16

MARDI Develops Taq DNA Polymerase 16

Stratagene Corporation Commercializes DNA Polymerases 16

Takara Bio Launches PrimeSTAR HS DNA Polymerase 16

9. RECENT INDUSTRY ACTIVITY 17

Thermo Fisher Scientific Acquires Finnzymes 17

Verenium and Add Food Service Enter into an Agreement 17

Verenium and Syngenta End
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related biology technology :

1. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
2. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
3. Forward step in forecasting global warming
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. Bionovo to Present at Canaccord Adams Global Growth Conference
6. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
7. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
10. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
11. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... The National Necrotizing Fasciitis Foundation ... by doctors at Vanderbilt University Hospital in ... and Dr. John Crew , director of the ... Center in Daly City, CA. ... pioneered by Dr. Crew, that had previously saved the ...
(Date:8/27/2015)... ... ... Inc. Magazine released its annual list of the 5,000 fastest-growing privately held ... the three years through 2014. Being named to the Inc. 5000 list designates a ... , “We are thrilled to make the Inc. 5000 list for 2015,” stated ...
(Date:8/26/2015)... , Aug. 26, 2015 /PRNewswire/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended June ... in Canadian dollars and presented under International Financial ... activities with respect to our Oral Amp B ... contract manufacturer," said Andrew Rae , President ...
(Date:8/26/2015)... Aug. 26, 2015 Intrexon Corporation (NYSE: ... the closing of its previously announced public offering of ... underwriters of their option to purchase an additional 731,707 ... of $41.00 per share.  The exercise of the underwriters, ... stock sold by Intrexon to 5,609,756 shares and increased ...
Breaking Biology Technology:Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4
... Reportlinker.com announces that a new market research ... Established and Emerging Biotech Clusters ... There has been widespread interest ... companies and related organizations. It is important ...
... Keryx Biopharmaceuticals (Nasdaq: KERX ) today ... component of its Phase 3 registration program of Zerenex™, ... of elevated serum phosphorus levels, or hyperphosphatemia, in patients ... Phase 3 registration program, which is being conducted pursuant ...
... The ALS Therapy Development Institute (ALS TDI) and ... their current research collaboration agreement to test additional ... stop the progression of Amyotrophic Lateral Sclerosis (ALS, ... collaboration is based on encouraging results from early-stage ...
Cached Biology Technology:Established and Emerging Biotech Clusters 2Established and Emerging Biotech Clusters 3Established and Emerging Biotech Clusters 4Established and Emerging Biotech Clusters 5Established and Emerging Biotech Clusters 6Established and Emerging Biotech Clusters 7Established and Emerging Biotech Clusters 8Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in Zerenex™ (Ferric Citrate) Phase 3 Long-Term Study 2Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in Zerenex™ (Ferric Citrate) Phase 3 Long-Term Study 3Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in Zerenex™ (Ferric Citrate) Phase 3 Long-Term Study 4ALS Therapy Development Institute and Aestus Therapeutics, Inc., Expand Collaboration on Development of Novel ALS Therapies 2ALS Therapy Development Institute and Aestus Therapeutics, Inc., Expand Collaboration on Development of Novel ALS Therapies 3
(Date:8/20/2015)... The wearable technology market has traditionally ... healthy. However, wearable technology has the potential to ... improve diagnostic capabilities and therapeutic outcomes. Today, Leaf ... Technologies Conference 2015 , where Barrett Larson ... healthcare.    "Over the past decade, ...
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
(Date:8/17/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... The new marketing campaign is being spearheaded by an ... ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ). ... driven marketing and brand awareness and has a client ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3
... that one of the cell's largest families of signaling ... development of nerve cells, also controls nerve cells' ability ... memory. These findings, the first to link these molecular ... the May issue of Nature Cell Biology, published in ...
... of BioModels, the world's first database of annotated ... collaboration led by the European Bioinformatics Institute (UK) ... develops open-source standards to describe biological systems. Other ... Systems Biology Institute (Japan) and Stellenbosch University (South ...
... of medical scientists has made an important advance in ... cancer in the industrialized world. Professor Jeremy R. Jass, ... at McGill University in Montreal, and colleagues in Australia ... cancer can be inherited. The new syndrome is characterized ...
Cached Biology News:Structure-building cell signals also may influence learning and memory 2Structure-building cell signals also may influence learning and memory 3A new way to share models of biological systems 2Important discovery about second most fatal cancer 2
... For separation and ... Efficient separation of nuclei from ... in sample complexity, greatly facilitating ... Subfractionation of nucleic acid binding ...
... of Eagle's medium have been ... The most widely used modification ... is a modification of Minimum ... contains a higher concentration of ...
... The EpiTect Bisulfite Kit enables ... uracils in less than 6 hours. ... innovative protection against DNA degradation and ... to guarantee fast and reliable results ...
Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...
Biology Products: